-
-
Overview
-
Please contact us at for specific academic pricing.
Background
Antiandrogen that inhibits type II 5α reductase (IC50 = 65 nM). Suppresses the conversion of testosterone to dihydrotestosterone. Reduces prostatic dihydrotestosterone levels and prostate size in vivo. Orally active.
-
- Properties
-
Overview